Trial: 202103185

A Phase II Study of U3-1402 in Patients with Metastatic Breast Cancer

Phase

II (Cancer Control)

Principal Investigator

Bagegni, Nusayba

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov